Modulation of cisplatin sensitivity by taxol in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines
โ Scribed by K. Yamamoto; Y. Kikuchi; K. Kudoh; I. Nagata
- Publisher
- Springer-Verlag
- Year
- 2000
- Tongue
- English
- Weight
- 171 KB
- Volume
- 126
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## BACKGROUND. Stage 111 ovarian carcinoma has shown resistance to adjuvant chemotherapy following surgical cytoreduction. With recurrence of ovarian carcinoma, cell lines may develop resistance to previously used chemotherapy. This contributes to the fact that survival rates for patients with ova
## Abstract This study was undertaken to elucidate the mechanism(s) of potentiation of cisplatin (CDDP) cytotoxicity by interferon ฮฑโ2a (IFN ฮฑโ2a) in human squamous carcinoma cell lines SCCโ25 and SCCโ4. IFN ฮฑโ2a treatment significantly increased the cytotoxicity of CDDP in both cell lines in a dos